María Soledad Lucero

María Soledad Lucero

Auto-generated profile, based on publicly available information

María Soledad Lucero

Laboratorio de Inmunología y Vacunas Aviares

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
CSClaudia Silberstein
Claudia Silberstein
MLMaría S. Lucero
María S. Lucero
EZElsa Zotta
Elsa Zotta
DCDiane P. Copeland
Diane P. Copeland
LLLi Lingyun
Li Lingyun
CICristina Ibarra
Cristina Ibarra

1 May 2013 in Vaccine
Verified
Journal Article
Closed access
EGEvangelina Gómez
Evangelina Gómez
MLMaría Soledad Lucero
María Soledad Lucero
SZSilvina Chimeno Zoth
Silvina Chimeno Zoth
JCJuan Manuel Carballeda
Juan Manuel Carballeda
MGMaría José Gravisaco
María José Gravisaco
ABAnalía Berinstein
Analía Berinstein

1 August 2019 in Vaccine
Verified
Journal Article
Closed access
MLMaría S. Lucero
María S. Lucero
MRMatías Richetta
Matías Richetta
SZSilvina Chimeno Zoth
Silvina Chimeno Zoth
JJJuan Jaton
Juan Jaton
SPSilvina Pinto
Silvina Pinto
EGEvangelina Gómez
Evangelina Gómez

17 May 2012 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MLMaría Soledad Lucero
María Soledad Lucero
FMFederico Mirarchi
Federico Mirarchi
Jorge GoldsteinJorge Goldstein
Jorge Goldstein
CSClaudia Silberstein
Claudia Silberstein

1 January 2017 in Vaccine
Verified
Journal Article
Open access
MRMatías Richetta
Matías Richetta
EGEvangelina Gómez
Evangelina Gómez
MLMaría Soledad Lucero
María Soledad Lucero
SZSilvina Chimeno Zoth
Silvina Chimeno Zoth
MGMaría José Gravisaco
María José Gravisaco
ABAnalía Berinstein
Analía Berinstein
Different immunogens such as subunit, DNA or live viral-vectored vaccines against Infectious Bursal Disease virus (IBDV) have been evaluated in the last years. However, the heterologous prime-boost approach using recombinant modified vaccinia Ankara virus (rMVA), which has shown promising results in both mammals and chickens, has not been tried against this pathogen yet. IBD is a highly contagious and immunosuppressive disease of poultry that affects mainly young chicks. It is caused by IBDV, a double-stranded RNA virus carrying its main antigenic epitopes on the capsid protein VP2. Our objective was to evaluate the immune response elicited by two heterologous prime-boost schemes combining an rMVA carrying the VP2 mature gene (rVP2) and a recombinant VP2 protein produced in Nicotiana benthamiana (pVP2), and to compare them with the performance of the homologous pVP2-pVP2 scheme usually used in our laboratory. The SPF chickens immunized with the three evaluated schemes elicited significantly higher anti-VP2 antibody titers (p<0.001) and seroneutralizing titers (p<0.05) and had less T-cell infiltration (p<0.001), histological damage (p<0.001) and IBDV particles (p<0.001) in their bursae of Fabricius when compared with control groups. No significant differences were found between both heterologous schemes and the homologous one. However, the rVP2-pVP2 scheme showed significantly higher anti-VP2 antibody titers than pVP2-rVP2 and a similar tendency was found in the seroneutralization assay. Conversely, pVP2-rVP2 had the best performance when evaluated through bursal parameters despite having a less potent humoral immune response. These findings suggest that the order in which rVP2 and pVP2 are combined can influence the immune response obtained. Besides, the lack of a strong humoral immune response did not lessen the ability to protect from IBDV challenge. Therefore, further research is needed to evaluate the mechanisms by which these immunogens are working in order to define the combination that performs better against IBDV.

1 December 2014 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
JCJuan Manuel Carballeda
Juan Manuel Carballeda
SZSilvina Chimeno Zoth
Silvina Chimeno Zoth
EGEvangelina Gómez
Evangelina Gómez
MLMaría Soledad Lucero
María Soledad Lucero
MGMaría José Gravisaco
María José Gravisaco
ABAnalía Berinstein
Analía Berinstein
The immune response elicited by the oral inoculation of an intermediate strain of infectious bursal disease virus was studied in chickens. A strong over expression of IL-6, IL-8, IFNα and IFNγ was observed in bursa at 3 days post inoculation together with an increase in splenic NO2 release. An influx of T-lymphocytes was also detected.